301333 诺思格
已收盘 12-17 15:00:00
资讯
新帖
简况
诺思格（301333）披露召开2025年第三次临时股东大会通知，12月09日股价上涨0.38%
证券之星 · 12-09
诺思格（301333）披露召开2025年第三次临时股东大会通知，12月09日股价上涨0.38%
11月18日诺思格现1笔折价19.44%的大宗交易 合计成交207.58万元
证券之星 · 11-18
11月18日诺思格现1笔折价19.44%的大宗交易 合计成交207.58万元
诺思格：自主研发Ai平台提高医药研发效率
证券之星 · 11-05
诺思格：自主研发Ai平台提高医药研发效率
股市必读：诺思格（301333）登10月31日交易所龙虎榜
证券之星 · 11-03
股市必读：诺思格（301333）登10月31日交易所龙虎榜
10月31日诺思格（301333）龙虎榜数据：机构净买入1.05亿元（3日），北向资金净买入2639.4万元（3日）
证券之星 · 10-31
10月31日诺思格（301333）龙虎榜数据：机构净买入1.05亿元（3日），北向资金净买入2639.4万元（3日）
诺思格最新公告：公司经营情况正常无应披露而未披露的重大事项
证券之星 · 10-31
诺思格最新公告：公司经营情况正常无应披露而未披露的重大事项
诺思格（301333）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 10-30
诺思格（301333）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
股市必读：诺思格10月29日涨停收盘，收盘价61.92元
证券之星 · 10-30
股市必读：诺思格10月29日涨停收盘，收盘价61.92元
诺思格(301333.SZ)发布前三季度业绩，归母净利润9556.68万元，增长13.21%
智通财经 · 10-28
诺思格(301333.SZ)发布前三季度业绩，归母净利润9556.68万元，增长13.21%
诺思格（301333）披露2025年第三季度报告，10月28日股价上涨0.39%
证券之星 · 10-28
诺思格（301333）披露2025年第三季度报告，10月28日股价上涨0.39%
诺思格新注册《医药试验数据标准化平台V1.0》项目的软件著作权
证券之星 · 10-24
诺思格新注册《医药试验数据标准化平台V1.0》项目的软件著作权
诺思格（301333）披露2025年员工持股计划非交易过户完成，10月23日股价上涨0.14%
证券之星 · 10-23
诺思格（301333）披露2025年员工持股计划非交易过户完成，10月23日股价上涨0.14%
诺思格（301333）披露高级管理人员变动公告，10月9日股价下跌1.36%
证券之星 · 10-09
诺思格（301333）披露高级管理人员变动公告，10月9日股价下跌1.36%
股市必读：诺思格（301333）9月10日董秘有最新回复
证券之星 · 09-11
股市必读：诺思格（301333）9月10日董秘有最新回复
诺思格：公司的竞争优势体现在试验设计方面创新性的技术领先以及项目执行层面的质量和口碑
证券之星 · 09-10
诺思格：公司的竞争优势体现在试验设计方面创新性的技术领先以及项目执行层面的质量和口碑
诺思格(301333.SZ)拟推2025年员工持股计划 资金总额不超1500万元
智通财经网 · 09-05
诺思格(301333.SZ)拟推2025年员工持股计划 资金总额不超1500万元
诺思格：公司目前业务中大部分为创新药
证券之星 · 09-04
诺思格：公司目前业务中大部分为创新药
诺思格（301333）2025年中报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 08-29
诺思格（301333）2025年中报简析：营收净利润同比双双增长，应收账款上升
股市必读：诺思格中报 - 第二季度单季净利润同比下降1.18%
证券之星 · 08-29
股市必读：诺思格中报 - 第二季度单季净利润同比下降1.18%
图解诺思格中报：第二季度单季净利润同比下降1.18%
证券之星 · 08-28
图解诺思格中报：第二季度单季净利润同比下降1.18%
公司概况
公司名称：
诺思格(北京)医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-08-02
主营业务：
诺思格(北京)医药科技股份有限公司的主营业务是为全球的医药企业和科研机构提供综合的药物临床研发全流程一体化服务。公司的主要产品是药物临床。
发行价格：
78.88
{"stockData":{"symbol":"301333","market":"SZ","secType":"STK","nameCN":"诺思格","latestPrice":57.23,"timestamp":1765954992000,"preClose":55.43,"halted":0,"volume":1805920,"delay":0,"changeRate":0.0325,"floatShares":57170200,"shares":96581299,"eps":1.5673,"marketStatus":"已收盘","change":1.8,"latestTime":"12-17 15:00:00","open":55,"high":57.64,"low":54.95,"amount":103000000,"amplitude":0.0485,"askPrice":57.23,"askSize":14,"bidPrice":57.22,"bidSize":5,"shortable":0,"etf":0,"ttmEps":1.5673,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"adjPreClose":55.43,"symbolType":"stock","openAndCloseTimeList":[[1765935000000,1765942200000],[1765947600000,1765954800000]],"highLimit":60.97,"lowLimit":49.89,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":96581256,"isCdr":false,"pbRate":2.79,"roa":"--","peRate":36.515026,"roe":"5.08%","epsLYR":1.47,"committee":0.682403,"marketValue":5527000000,"turnoverRate":0.0316,"status":0,"floatMarketCap":3272000000},"requestUrl":"/m/hq/s/301333/wiki","defaultTab":"wiki","newsList":[{"id":"2590342382","title":"诺思格（301333）披露召开2025年第三次临时股东大会通知，12月09日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590342382","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590342382?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:20","pubTimestamp":1765290007,"startTime":"0","endTime":"0","summary":"截至2025年12月9日收盘，诺思格报收于55.75元，较前一交易日上涨0.38%，最新总市值为53.84亿元。该股当日开盘55.36元，最高56.92元，最低55.19元，成交额达1.03亿元，换手率为3.21%。近日，诺思格（北京）医药科技股份有限公司发布公告，宣布将于2025年12月29日召开2025年第三次临时股东大会，会议采取现场表决与网络投票相结合的方式。股权登记日为2025年12月23日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900040733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2584987534","title":"11月18日诺思格现1笔折价19.44%的大宗交易 合计成交207.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584987534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584987534?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:48","pubTimestamp":1763455709,"startTime":"0","endTime":"0","summary":"证券之星消息，11月18日诺思格发生大宗交易，交易数据如下：大宗交易成交价格48.5元，相对当日收盘价折价19.44%，成交4.28万股，成交金额207.58万元，买方营业部为方正证券股份有限公司上海杨高南路证券营业部，卖方营业部为华福证券有限责任公司苏州分公司。近三个月该股共发生1笔大宗交易，合计成交428.0手，折价成交1笔。截至2025年11月18日收盘，诺思格报收于60.2元，下跌0.63%，换手率4.76%，成交量2.72万手，成交额1.66亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800020692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2581069715","title":"诺思格：自主研发Ai平台提高医药研发效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2581069715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581069715?lang=zh_cn&edition=full","pubTime":"2025-11-05 11:36","pubTimestamp":1762313766,"startTime":"0","endTime":"0","summary":"证券之星消息，诺思格(301333)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问：现在AI越来越强大，想必在创新药领域也可以有很大发展空间，目前公司的AI平台为公司带来哪些优势？公司有持续投入AI平台的创新与迭代吗？诺思格回复：尊敬的投资者您好！公司密切关注Ai技术，自主研发Ai平台，以提高医药研发外包服务效率。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500014025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","09939","BK1161","BK1574","159938","BK0216","BK1515"],"gpt_icon":0},{"id":"2580459231","title":"股市必读：诺思格（301333）登10月31日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2580459231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580459231?lang=zh_cn&edition=full","pubTime":"2025-11-03 06:04","pubTimestamp":1762121061,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，诺思格报收于68.59元，上涨7.0%，换手率14.44%，成交量8.25万手，成交额5.58亿元。龙虎榜上榜沪深交易所2025年10月31日公布的交易公开信息显示，诺思格因连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。公司公告汇总股票交易异常波动公告诺思格（北京）医药科技股份有限公司股票于2025年10月29日、10月30日、10月31日连续三个交易日收盘价格涨幅偏离值累计超过30%，属于股票交易异常波动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300001299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2579454803","title":"10月31日诺思格（301333）龙虎榜数据：机构净买入1.05亿元（3日），北向资金净买入2639.4万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2579454803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579454803?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:47","pubTimestamp":1761904034,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年10月31日公布的交易公开信息显示，诺思格因连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年10月31日收盘，诺思格报收于68.59元，上涨7.0%，换手率14.44%，成交量8.25万手，成交额5.58亿元。从龙虎榜公布的三日买卖数据来看，机构合计净买入1.05亿元，北向资金合计净买入2639.4万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100037723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2579945963","title":"诺思格最新公告：公司经营情况正常无应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2579945963","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579945963?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:17","pubTimestamp":1761902279,"startTime":"0","endTime":"0","summary":"诺思格(301333.SZ)公告称，公司股票于2025年10月29日至10月31日连续三个交易日收盘价格涨幅偏离值累计超过30%，属于股票交易异常波动情况。经核实，公司前期披露的信息无需要更正或补充之处，近期公共传媒未报道可能影响公司股价的重大信息，公司经营环境未发生重大变化。公司、控股股东和实际控制人无应披露而未披露的重大事项或筹划中的事项。控股股东和实际控制人在股票交易异常波动期间未买卖公司股票。公司将继续履行信息披露义务，相关信息以指定媒体刊登为准。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100035599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2579581651","title":"诺思格（301333）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2579581651","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579581651?lang=zh_cn&edition=full","pubTime":"2025-10-30 06:43","pubTimestamp":1761777797,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期诺思格发布2025年三季报。截至本报告期末，公司营业总收入6.07亿元，同比上升8.09%，归母净利润9556.68万元，同比上升13.21%。本报告期诺思格公司应收账款体量较大，当期应收账款占最新年报归母净利润比达97.94%。去年的净利率为19.06%，算上全部成本后，公司产品或服务的附加值高。持有诺思格最多的基金为信澳优享生活混合A，目前规模为1.92亿元，最新净值1.1259，较上一交易日上涨1.54%，近一年上涨41.91%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000007132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333"],"gpt_icon":0},{"id":"2579600181","title":"股市必读：诺思格10月29日涨停收盘，收盘价61.92元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579600181","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579600181?lang=zh_cn&edition=full","pubTime":"2025-10-30 01:37","pubTimestamp":1761759474,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘，诺思格报收于61.92元，上涨20.0%，涨停，换手率16.62%，成交量9.5万手，成交额5.58亿元。当日关注点来自交易信息汇总：诺思格10月29日涨停收盘，收盘价61.92元，盘中7次打开涨停，最终封单资金为723.1万元。来自龙虎榜上榜：诺思格因日涨幅达15%登龙虎榜，为近5个交易日内首次上榜。交易信息汇总诺思格10月29日涨停收盘，收盘价61.92元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000001886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2578342934","title":"诺思格(301333.SZ)发布前三季度业绩，归母净利润9556.68万元，增长13.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578342934","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578342934?lang=zh_cn&edition=full","pubTime":"2025-10-28 18:00","pubTimestamp":1761645637,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺思格(301333.SZ)发布2025年三季度报告，该公司前三季度营业收入为6.07亿元，同比增长8.09%。归属于上市公司股东的净利润为9556.68万元，同比增长13.21%。归属于上市公司股东的扣除非经常性损益的净利润为8133.34万元，同比增长22.47%。基本每股收益为1元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301333"],"gpt_icon":0},{"id":"2578893149","title":"诺思格（301333）披露2025年第三季度报告，10月28日股价上涨0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578893149","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578893149?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:53","pubTimestamp":1761645216,"startTime":"0","endTime":"0","summary":"截至2025年10月28日收盘，诺思格报收于51.6元，较前一交易日上涨0.39%，最新总市值为49.84亿元。公司近日发布公告称，诺思格（北京）医药科技股份有限公司第四届监事会第十一次会议于2025年10月28日以现场结合通讯方式召开，会议审议通过《关于<2025年第三季度报告全文>的议案》。监事会认为公司《2025年第三季度报告》内容真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏。相关内容详见公司同日披露于巨潮资讯网的《2025年第三季度报告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800033362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2577827975","title":"诺思格新注册《医药试验数据标准化平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2577827975","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577827975?lang=zh_cn&edition=full","pubTime":"2025-10-24 01:38","pubTimestamp":1761241090,"startTime":"0","endTime":"0","summary":"证券之星消息，近日诺思格（301333）新注册了《医药试验数据标准化平台V1.0》项目的软件著作权。今年以来诺思格新注册软件著作权2个，较去年同期减少了66.67%。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了3067.26万元，同比增8.59%。通过天眼查大数据分析，诺思格（北京）医药科技股份有限公司共对外投资了7家企业，参与招投标项目10次；财产线索方面有商标信息9条，专利信息3条，著作权信息66条；此外企业还拥有行政许可4个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400001397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","09939","301333","BK1515","BK0216","159938","BK1574"],"gpt_icon":0},{"id":"2577585504","title":"诺思格（301333）披露2025年员工持股计划非交易过户完成，10月23日股价上涨0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577585504","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577585504?lang=zh_cn&edition=full","pubTime":"2025-10-23 22:37","pubTimestamp":1761230232,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，诺思格报收于49.73元，较前一交易日上涨0.14%，最新总市值为48.03亿元。近日，诺思格发布关于2025年员工持股计划非交易过户完成的公告。本次员工持股计划资金总额不超过1,500.00万元，份额上限为1,500.00万份，参加人数不超过40人。本次过户完成后，公司回购专用账户剩余股份590,000股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300037941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2574691001","title":"诺思格（301333）披露高级管理人员变动公告，10月9日股价下跌1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574691001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574691001?lang=zh_cn&edition=full","pubTime":"2025-10-09 22:56","pubTimestamp":1760021776,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，诺思格报收于54.25元，较前一交易日下跌1.36%，最新总市值为52.4亿元。近日，诺思格（北京）医药科技股份有限公司发布公告，公司首席医学官、副总经理李继刚先生及副总经理刘萍女士分别因工作重心调整，申请辞去公司副总经理职务，申请自提交董事会之日起生效。截至公告披露日，李继刚先生持有公司股份31,950股，约占总股本的0.03%；刘萍女士持有公司股份27,000股，约占总股本的0.03%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900034874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2566377989","title":"股市必读：诺思格（301333）9月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2566377989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566377989?lang=zh_cn&edition=full","pubTime":"2025-09-11 02:02","pubTimestamp":1757527339,"startTime":"0","endTime":"0","summary":"截至2025年9月10日收盘，诺思格报收于60.01元，上涨2.3%，换手率10.58%，成交量6.05万手，成交额3.61亿元。董秘最新回复投资者： 请问公司8月31日和9月10日的股东人数分别是多少？股价受多重因素影响，请注意投资风险。当日关注点来自交易信息汇总：9月10日主力资金净流入1076.82万元，游资资金同步净流入1000.64万元，显示市场资金对个股呈积极介入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100001671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2566767518","title":"诺思格：公司的竞争优势体现在试验设计方面创新性的技术领先以及项目执行层面的质量和口碑","url":"https://stock-news.laohu8.com/highlight/detail?id=2566767518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566767518?lang=zh_cn&edition=full","pubTime":"2025-09-10 15:54","pubTimestamp":1757490847,"startTime":"0","endTime":"0","summary":"证券之星消息，诺思格(301333)09月10日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司是否有做市值管理工作？与板块大盘差距过大的原因是什么，在创新药领域有何优势和布局？诺思格回复：尊敬的投资者您好！公司的竞争优势体现在试验设计方面创新性的技术领先以及项目执行层面的质量和口碑。股价受多重因素影响，请注意投资风险。公司将持续关注市场动态，努力提升业绩，加强市值管理，为投资者创造更大的价值。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091000023232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216","000973.SH"],"gpt_icon":0},{"id":"2565455785","title":"诺思格(301333.SZ)拟推2025年员工持股计划 资金总额不超1500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565455785","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565455785?lang=zh_cn&edition=full","pubTime":"2025-09-05 19:17","pubTimestamp":1757071065,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺思格(301333.SZ)披露2025年员工持股计划(草案)，员工持股计划的资金来源为公司计提的奖励基金及法律法规允许的其他方式，资金总额不超过1500万元。本员工持股计划股票规模为不超过38.58万股，标的股票来源为公司回购专用账户中的公司A股，购买回购股票的价格为38.88元/股。本员工持股计划的存续期为36个月，自公司公告最后一笔标的股票过户至本员工持股计划名下之日起算。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2564320342","title":"诺思格：公司目前业务中大部分为创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2564320342","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564320342?lang=zh_cn&edition=full","pubTime":"2025-09-04 11:33","pubTimestamp":1756956805,"startTime":"0","endTime":"0","summary":"证券之星消息，诺思格09月03日在投资者关系平台上答复投资者关心的问题。公司目前业务中大部分为创新药，国际多中心项目比较少。公司坚持降本增效，自主研发Ai平台用于相关服务领域，以提高内部工作效率并控制成本。在实际业务中，公司的竞争优势体现在试验设计方面创新性的技术领先以及项目执行层面的质量和口碑。公司重视股东利益和投资者回报，并将严格按照法律法规的要求及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400014194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1574","301333","BK0216","159992","06978"],"gpt_icon":0},{"id":"2563806760","title":"诺思格（301333）2025年中报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2563806760","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563806760?lang=zh_cn&edition=full","pubTime":"2025-08-29 06:46","pubTimestamp":1756421172,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期诺思格发布2025年中报。截至本报告期末，公司营业总收入3.8亿元，同比上升0.18%，归母净利润6111.61万元，同比上升4.45%。按单季度数据看，第二季度营业总收入2.07亿元，同比上升2.56%，第二季度归母净利润3504.23万元，同比下降1.18%。本报告期诺思格应收账款上升，应收账款同比增幅达38.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900007424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333"],"gpt_icon":0},{"id":"2563066354","title":"股市必读：诺思格中报 - 第二季度单季净利润同比下降1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563066354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563066354?lang=zh_cn&edition=full","pubTime":"2025-08-29 04:02","pubTimestamp":1756411345,"startTime":"0","endTime":"0","summary":"截至2025年8月28日收盘，诺思格报收于51.48元，下跌0.39%，换手率5.06%，成交量2.89万手，成交额1.49亿元。来自：诺思格2025年中报显示归母净利润同比增长4.45%，扣非净利润同比增长9.52%。股本股东变化股东户数变动近日诺思格披露，截至2025年6月30日公司股东户数为1.04万户，较6月20日增加210.0户，增幅为2.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900004237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333"],"gpt_icon":0},{"id":"2562413729","title":"图解诺思格中报：第二季度单季净利润同比下降1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562413729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562413729?lang=zh_cn&edition=full","pubTime":"2025-08-28 01:37","pubTimestamp":1756316268,"startTime":"0","endTime":"0","summary":"证券之星消息，诺思格2025年中报显示，公司主营收入3.8亿元，同比上升0.18%；归母净利润6111.61万元，同比上升4.45%；扣非净利润5090.84万元，同比上升9.52%；其中2025年第二季度，公司单季度主营收入2.07亿元，同比上升2.56%；单季度归母净利润3504.23万元，同比下降1.18%；单季度扣非净利润3049.34万元，同比上升1.91%；负债率18.11%，投资收益569.87万元，财务费用-186.06万元，毛利率37.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800001420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765964146125,"stockEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.099},{"period":"3month","weight":-0.034},{"period":"6month","weight":0.2056},{"period":"1year","weight":0.0167},{"period":"ytd","weight":0.1125}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.0133},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.1411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"诺思格(北京)医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"8734人(较上一季度减少16.18%)","perCapita":"6545股","listingDate":"2022-08-02","address":"北京市通州区经济开发区东区创益西路518号","registeredCapital":"9658万元","survey":" 诺思格(北京)医药科技股份有限公司的主营业务是为全球的医药企业和科研机构提供综合的药物临床研发全流程一体化服务。公司的主要产品是药物临床。","listedPrice":78.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺思格(301333)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺思格(301333)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺思格,301333,诺思格股票,诺思格股票老虎,诺思格股票老虎国际,诺思格行情,诺思格股票行情,诺思格股价,诺思格股市,诺思格股票价格,诺思格股票交易,诺思格股票购买,诺思格股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺思格(301333)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺思格(301333)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}